Amylin Pharmaceuticals (AMLN) Tops Q2 EPS by 2c
Tweet Send to a Friend
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) reports a Q2 loss of $0.47, 2 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
